名稱 | bTMB-P1 (22.91) Reference Standard |
型號(hào) | CBP80001-10 |
報(bào)價(jià) | ![]() |
特點(diǎn) | bTMB-P1 (22.91) Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 認(rèn)識(shí)下北京細(xì)胞庫的質(zhì)量管理要求
- 腫瘤細(xì)胞能無限分裂的原因有哪些?
- 【新品上線】AXL篩選模型
- 【新品發(fā)布】血液系統(tǒng)惡性腫瘤標(biāo)準(zhǔn)品-27基因-38位點(diǎn)
- AVβ6靶點(diǎn)細(xì)胞篩選模型
- 【基因編輯產(chǎn)品新品上市】MET Ex14 skipping新添成員
- Canine IL-31細(xì)胞篩選模型
- 圣誕節(jié)日,這株腫瘤細(xì)胞你的圣誕襪里,有嗎
- 【靶點(diǎn)模型+診斷質(zhì)控】c-Kit常見突變的藥物開發(fā)和診斷
- 【產(chǎn)品推介】IL23抗體篩選模型
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 其他類別 > CBP80001-10bTMB-P1 (22.91) Reference Standard

- 詳細(xì)內(nèi)容
CBP80001-10 | |||||||||||||||||||||||||||||||||||||||||||||||
I. Background | |||||||||||||||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
| |||||||||||||||||||||||||||||||||||||||||||||||